Published

Screening and confirmation of psilocin, mitragynine, phencyclidine, ketamine and ketamine metabolites by liquid chromatography-tandem mass spectrometry

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Journal of Analytical Toxicology
Date: 2024-03-01
Source: Crossref
DOI: 10.1093/jat/bkae002
PubMed: 38287693

Authors

Wood Madeleine E Brown Glenna J Karschner Erin L Seither Joshua Z Brown Jordan T Knittel Jessica L Walterscheid Jeffrey P

Watch author

Derived topics and classifications

psilocin Safety Toxicity Clinical Trial

Citation graph

40 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

10.1016/j.neuropharm.2018.02.018 10.1016/j.euroneuro.2020.02.001 10.1192/bjp.bp.111.103309 10.1177/0269881119857204 10.1021/acsptsci.0c00176 10.1016/j.bmcl.2005.06.104 10.1016/s0379-0738(00)00213-9 10.1093/jat/30.5.342 10.1016/j.jchromb.2003.08.030 10.1007/s00414-012-0796-1 10.1007/s00414-011-0652-8 10.1002/dta.422

Indexed papers citing this DOI

Screening and confirmation of psilocin, mitragynine, phencyclidine, ketamine and ketamine metabolites by liquid chromatography-tandem mass spectrometry2024-03-01

Related papers

No close related records were found yet.